Price Alert

Sanara MedTech Inc. (SMTI)

NASDAQ: SMTI · Real-Time Price · USD

30.40

-1.52 (-4.76%)

At close: Aug 14, 2025, 3:59 PM

30.44

0.13%

Pre-market: Aug 15, 2025, 04:00 AM EDT

-4.76% (1D)

Bid	30
Market Cap	270.19M
Revenue (ttm)	91.57M
Net Income (ttm)	-11.43M
EPS (ttm)	-1.34
PE Ratio (ttm)	-22.69
Forward PE	-17.89
Analyst	Strong Buy

Ask	30.8
Volume	60,873
Avg. Volume (20D)	44,764
Open	31.70
Previous Close	31.92
Day's Range	29.61 - 31.70
52-Week Range	23.53 - 39.08
Beta	1.26

About SMTI

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SMTI

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SMTI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Sanara MedTech has released their quartely earnings on Aug 13, 2025:

Revenue of $25.83M misses estimates by $789K, with 28.14% YoY growth.

EPS of -0.23 exceeds estimates by 0.10, with 43.90% YoY growth.

Next Earnings Release

Sanara MedTech Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

-12.58%

Sansara MedTech shares are trading lower after the... Unlock content with Pro Subscription

News

1 day ago · seekingalpha.com

Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI ) Q2 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Elizabeth B. Taylor - Chief Financial Officer Ronald T.

2 days ago · zacks.com

Sanara MedTech Inc. (SMTI) Reports Q2 Loss, Tops Revenue Estimates

Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.41 per share a year ago.

2 months ago · seekingalpha.com

Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb

Sanara MedTech's surgical revenue grew 26% year-over-year in Q1, with a gross margin of 92%. Surgical adjusted EBITDA was $2.7 million in Q1, while THP correspondingly posted a loss of $2 million. Hig...